Stacie Lindsey։ Cholangiocarcinoma Foundation Webinar Highlights Latest Clinical Trials and Treatments
Stacie Lindsey, CEO at Cholangiocarcinoma Foundation, shared on LinkedIn: “The Cholangiocarcinoma Foundation team was pleased to host an informative webinar with industry partners AstraZeneca…
Read the full articleYou might also wanna read
Medscape/PBC Foundation Educational Event: PBC Case Challenges and Solutions
Your patients with primary biliary cholangitis (PBC) may be suffering from itch and fatigue in silence.
mdsc.pe·17d agoA Phase III Trial of Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
Conditions : Intrahepatic Cholangiocarcinoma (Icc) Interventions : Drug: Gemcitabine; Drug: Cisplatin; Drug: Tislelizumab; Drug: Lenvatinib;
The Week in Cancer News: Cholangiocarcinoma Therapy and Lung Cancer Treatment Rates
The FDA approved a therapy for bile duct cancer, and most older adults with stage IV lung cancer never receive systemic treatment. The post
HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
Conditions : Liver Cancer Interventions : Device: DEB-TACE; Drug: Toripalimab; Drug: Lenvatinib; Drug: Gemcitabine; Drug: Oxaliplatin Sponso
Interview: Kyrexa launches £1.5m funding round for revolutionary Rimcazole canine cancer treatment
Dr Clare Knottenbelt, CEO of Kyrexa, discusses how the company is advancing canine cancer treatment with Rimcazole. The post Interview: Kyre
The Pancreatic Cancer Action Network Announces Leadership Updates to its Board of Directors and Scientific Medical Advisory Board for FY2027
Jul 1, 2026 - By Charaighn Sesock LOS ANGELES, CALIF. – (July 1, 2026) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofi
Comments
Sign in to join the conversation.
No comments yet. Be the first.